Edge Therapeutics, Inc. (Nasdaq: EDGE) announced that the first patient has been treated in NEWTON 2 (Nimodipine microparticles to Enhance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE